New drugs for low grade lymphoproliferative diseases Por Argiris Symeonidis

Obter o texto integral

Editorial: Hybrid or mixed myelodyplastic/myeloproliferative disorders: Current trends in diagnosis and treatment Por Argiris Symeonidis, Ulrich Germing

Obter o texto integral

Editorial: MDS: new scientific and clinical developments Por Sabine Blum, Argiris Symeonidis, Ulrich Germing

Obter o texto integral

PB2551: GAUCHER DISEASE CURRICULUM: INCORPORATING GAUCHER DISEASE IN THE FIELD OF HEMATOLOGY Por Argiris Symeonidis, Colm Bradley, Sam Salek

Obter o texto integral

Autophagy and oxidative stress modulation mediate Bortezomib resistance in prostate cancer. Por Kalliopi Zafeiropoulou, Georgios Kalampounias, Spyridon Alexis, Daniil Anastasopoulos, Argiris Symeonidis, Panagiotis Katsoris

Obter o texto integral

Autophagy and oxidative stress modulation mediate Bortezomib resistance in prostate cancer Por Kalliopi Zafeiropoulou, Georgios Kalampounias, Spyridon Alexis, Daniil Anastasopoulos, Argiris Symeonidis, Panagiotis Katsoris

Obter o texto integral

Allogeneic Hematopoietic Stem Cell Transplantation for Mixed or Overlap Myelodysplastic/Myeloproliferative Disorders Por Argiris Symeonidis, Spiros Chondropoulos, Evgenia Verigou, Vasileios Lazaris, Alexandra Kourakli, Panagiotis Tsirigotis

Obter o texto integral

Chronic Neutrophilic Leukemia: A Comprehensive Review of Clinical Characteristics, Genetic Landscape and Management Por Thomas P. Thomopoulos, Argiris Symeonidis, Alexandra Kourakli, Sotirios G. Papageorgiou, Vasiliki Pappa

Obter o texto integral

Prognostic Value of PSMB5 and Correlations with LC3II and Reactive Oxygen Species Levels in the Bone Marrow Mononuclear Cells of Bortezomib-Resistant Multiple Myeloma Patients Por Eva Plakoula, Georgios Kalampounias, Spyridon Alexis, Evgenia Verigou, Alexandra Kourakli, Kalliopi Zafeiropoulou, Argiris Symeonidis

Obter o texto integral

The Lipoprotein Transport System in the Pathogenesis of Multiple Myeloma: Advances and Challenges Por Vasileios Lazaris, Vasileios Lazaris, Aikaterini Hatziri, Argiris Symeonidis, Kyriakos E. Kypreos, Kyriakos E. Kypreos

Obter o texto integral

Immunophenotyping myelodysplastic neoplasms: the role of flow cytometry in the molecular classification era Por Evgenia Verigou, Theodora Chatzilygeroudi, Theodora Chatzilygeroudi, Vasileios Lazaris, Anne-Lise de Lastic, Argiris Symeonidis

Obter o texto integral

Integrating advanced analytical methods to assess epigenetic marks affecting response to hypomethylating agents in higher risk myelodysplastic syndrome Por Theodoros Nikolopoulos, Eleftherios Bochalis, Theodora Chatzilygeroudi, Vasiliki Chondrou, Irene Dereki, Katerina Athanasopoulou, John Zafeiropoulos, Kyriakos Bourikas, George P. Patrinos, Argiris Symeonidis, Argyro Sgourou

Obter o texto integral

Common cardiovascular biomarkers can independently predict outcome of patients with Myelodysplastic syndromes Por Ioannis Mitroulis, Vasileios Papadopoulos, Eleftheria Lamprianidou, Peter Mirtschink, Konstantinos Liapis, Kalliopi Zafeiropoulou, Alexandra Kourakli, Theodoros Moysiadis, Menelaos Papoutselis, George Vrachiolias, Argiris Symeonidis, Ioannis Kotsianidis

Obter o texto integral

PB2010: FIRST-LINE TREATMENT PATTERNS AND OUTCOMES AMONG PATIENTS WITH NEWLY DIAGNOSED MYELODYSPLASTIC SYNDROMES: A GLOBAL, RETROSPECTIVE OBSERVATIONAL COHORT STUDY Por Amer M. Zeidan, Aleksandra Butrym, Aylin Yucel, Gaurav Deshpande, Min Che, Tao Gu, Hong Xiao, Dimana Miteva, Jose Alberto Nadal, T. Kim Le, Argiris Symeonidis

Obter o texto integral

Impact of ZBTB7A hypomethylation and expression patterns on treatment response to hydroxyurea Por Vasiliki Chondrou, Eleana F. Stavrou, Georgios Markopoulos, Alexandra Kouraklis-Symeonidis, Vasilios Fotopoulos, Argiris Symeonidis, Efthymia Vlachaki, Panagiota Chalkia, George P. Patrinos, Adamantia Papachatzopoulou, Argyro Sgourou

Obter o texto integral

Whole transcriptome analysis of human erythropoietic cells during ontogenesis suggests a role of VEGFA gene as modulator of fetal hemoglobin and pharmacogenomic biomarker of treatm... Por Vasiliki Chondrou, Petros Kolovos, Argyro Sgourou, Alexandra Kourakli, Alexia Pavlidaki, Vlasia Kastrinou, Anne John, Argiris Symeonidis, Bassam R. Ali, Adamantia Papachatzopoulou, Theodora Katsila, George P. Patrinos

Obter o texto integral

P901: DARATUMUMAB, IXAZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA PRE-TREATED WITH A LENALIDOMIDE-BASED REGIMEN: FINAL OUTCOMES OF THE PHASE 2 DAR... Por Evangelos Terpos, Maria Gavriatopoulou, Eirini Katodritou, Evdoxia Hatjiharissi, Ioanna Dialoupi, Evgenia Verrou, Kyriaki Manousou, Stavros Gkolfinopoulos, Magdalini Migkou, Sosana Delimpasi, Argiris Symeonidis, Efstathios Kastritis, Meletios A. Dimopoulos

Obter o texto integral

Fetal hemoglobin induction in azacytidine responders enlightens methylation patterns related to blast clearance in higher-risk MDS and CMML Por Theodora Chatzilygeroudi, Vasiliki Chondrou, Ruben Boers, Stavroula Siamoglou, Katerina Athanasopoulou, Evgenia Verigou, Joost Gribnau, Spyridon Alexis, Vassiliki Labropoulou, Alexandra Kourakli, George P. Patrinos, Argyro Sgourou, Argiris Symeonidis

Obter o texto integral

ISATUXIMAB PLUS CARFILZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA AND SOFT-TISSUE PLASMACYTOMAS: IKEMA SUBGROUP ANALYSIS Por Mehmut TURGUT, Roman HAJEK, Tomas JELÍNEK, Philippe MOREAU, Thomas MARTIN, Ludek POUR, Gabor MIKALA, Argiris SYMEONIDIS, Sara BRINGHEN, Andreea RAWLINGS, Marie Laure RISSE, Helgi VAN DE VELDE, Ivan SPICKA

Obter o texto integral

Genome-wide analysis toward the epigenetic aetiology of myelodysplastic syndrome disease progression and pharmacoepigenomic basis of hypomethylating agents drug treatment response Por Stavroula Siamoglou, Ruben Boers, Maria Koromina, Joachim Boers, Anna Tsironi, Theodora Chatzilygeroudi, Vasileios Lazaris, Evgenia Verigou, Alexandra Kourakli, Wilfred F. J. van IJcken, Joost Gribnau, Argiris Symeonidis, George P. Patrinos

Obter o texto integral